Home News & Events Social media Social media What’s happening in ICON ICON Plc Reaching the right audience is a critical decision. Use the system that does the work for you. Journals & Congresses helps you compare your options on the data points most important to you in making your decision. Get a ... 4 Dec 1 View post View webpage ICON Plc Central laboratories are under more pressure than ever. Increasingly complex protocols, frequent amendments, and growing data demands require speed, agility, and uncompromising scientific integrity. At ICON Laboratories,... 4 Dec View post View webpage ICON Plc Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory subm... 4 Dec 1 View post View webpage ICON Plc In the dynamic world of life sciences, the consultancy sector is undergoing a transformation as cost pressures increase, speed to market needs accelerate and technology permeates every aspect. Against this backdrop, cl... 4 Dec View post View webpage ICON Plc Cardiovascular outcomes trials (CVOTs) are essential for demonstrating clinical value and meeting regulatory expectations but they’re also complex and resource-intensive. On December 8-10, connect with ICON experts at CV... 4 Dec 2 View post View webpage ICON Plc Early phase neurodegenerative trials require careful planning, a patient-first approach, and biomarker strategies that drive progress. Tune in to our recent ASCPT-hosted webinar, where we explored: - How to define target... 4 Dec View post View webpage ICON Plc Site activation delays cost trials time and trust. ICON’s new whitepaper shows how human-centred strategies accelerate startup and improve site satisfaction. Download now: https://ow.ly/f5EO50XB6ZL 3 Dec 3 View post View webpage ICON Plc 55% of sites report activation timelines of five months or longer. Our new whitepaper explores why, and how to fix it. Download now: https://ow.ly/j6RK50XB6ZW 3 Dec View post View webpage ICON Plc Learn how to build a JCA dossier that supports both EU-wide assessments and national reimbursement needs. Download the whitepaper: https://ow.ly/2wWF50XgHL8 #ValueCommunication #HEOR #HTA #ICONInsights 3 Dec View post View webpage ICON Plc Integrating advanced delivery systems, often accelerated by AI modelling, is a game-changer for biopharmaceutical success. In this article for BioPharm International, ICON’s Head of Regulatory CMC, Venkat Sunkara, MSc, M... 3 Dec View post View webpage ICON Plc Want to know what’s missing in next-gen drug delivery? In this article for BioPharm International, ICON’s Head of Regulatory CMC, Venkat Sunkara, outlines current product development trends happening in the world of bio... 3 Dec 1 View post View webpage ICON Plc How to navigate EU MAA Regulations and Registration Regulatory legislation in China differs substantially from that of the European Union. For Chinese biotech companies looking to enter this market it is critical to ass... 3 Dec View post View webpage
